Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$161.52+0.73 (+0.45%)
Close on Nov 2, 2026Market cap $308.21BP/E 22.6Yield –
Novartis Regulatory Submissions by Year
Novartis Regulatory Submissions: 29 in FY2025, unchanged from a year earlier.
Latest, FY2025
29
Period ended Dec 31, 2025
Change on a year earlier
0.0%
29 in FY2024
History
6 years
Since FY2020
Sources
4
Documents cited below
Where the FY2025 figure comes from
“| Submissions (US, EU, JP, China) | 29 | 29 | 35”
Source: Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗
Reported in ESG Data Summary 2025.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Regulatory Submissions | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 29 | 0.0% | Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗ |
| FY2024 | Dec 31, 2024 | 29 | +61.1% | Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗ |
| FY2023 | Dec 31, 2023 | 18 | -25.0% | Novartis Form 6-K (0001370368-25-000008) ↗ |
| FY2022 | Dec 31, 2022 | 24 | -29.4% | Novartis Form 6-K (0001370368-25-000008) ↗ |
| FY2021 | Dec 31, 2021 | 34 | +161.5% | Novartis Form 6-K (0001370368-24-000008) ↗ |
| FY2020 | Dec 31, 2020 | 13 | – | Novartis Form 6-K (0001370368-23-000009) ↗ |
Cite this data
StockData. (2026). Novartis Regulatory Submissions, annual FY2020–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/rd-submissions-major
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.